Strength in Numbers: Identifying Neoantigen Targets for Cancer Immunotherapy.
Cell
; 183(3): 591-593, 2020 10 29.
Article
en En
| MEDLINE
| ID: mdl-33125888
ABSTRACT
Targeting cancer neoantigens generated by tumor-exclusive somatic mutations is an attractive yet challenging strategy for the robust and specific elimination of tumor cells by cellular immunotherapy. In this issue of Cell, Wells et al. describe a consortium-based approach to optimize bioinformatics pipelines to sensitively and accurately predict immunogenic neoantigens from next-generation sequencing data.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Antígenos de Neoplasias
/
Neoplasias
Límite:
Humans
Idioma:
En
Revista:
Cell
Año:
2020
Tipo del documento:
Article